Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging
- Women who have planned surgical excision of a lesion or have had a baseline MBI study
as part of another MBI research protocol who are within 6-12 months of completing
breast surgery who are able and willing to return to Mayo Clinic for a follow up MBI
study once the 6-12 month interval is complete.
- Women who plan BCT for a malignant lesion or who are within 6-12 months of completing
breast conserving treatment and have had a baseline MBI study as part of another MBI
research protocol and are able and willing to return to Mayo Clinic for a follow up
- Women who do not require surgical excision of a breast lesion or breast conserving
treatment for breast cancer.
- Patients undergoing mastectomy.
- Women who are pregnant or lactating.
- Women who are taking hormonal contraception or hormone replacement therapy (vaginal
estrogen is permitted), or have used these agents within the previous 3 months.
- Women who have received chemotherapy within the previous 6 months or receive
chemotherapy as part of their cancer treatment.
- Men (due to the very low incidence of male breast cancer and the lack of any
available data regarding the use of scintimammography or MBI in men).
- Women under the age of 18 years.
- Women unable to sit comfortably during image acquisition.
- Women who are unable to return to Mayo Clinic for a follow up MBI scan 6-12 months
after surgical excision or 6-12 months after completing radiation therapy for breast